Seeking Alpha

Salix Pharmaceuticals (SLXP): Q1 EPS of $0.67 beats by $0.11. Revenue of $171.1M (+62% Y/Y). (PR)

Salix Pharmaceuticals (SLXP): Q1 EPS of $0.67 beats by $0.11. Revenue of $171.1M (+62% Y/Y). (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)